MedPath

The effect of pregabalin and diclofenac on post-cesarean pai

Phase 2
Conditions
Cesarean section.
Single liveborn infant, delivered by cesarean
Z38.01
Registration Number
IRCT20180902040931N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
48
Inclusion Criteria

Term pregnancy
Elective cesarean

Exclusion Criteria

Allergy to non-steroidal anti-inflammatory drugs or pregabalin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Post-cesarean pain severity. Timepoint: Every 6 hours for 24 hours. Method of measurement: Using visual analogue scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath